Novel Sulbactam Combinations Against Multidrug-Resistant Acinetobacter Baumannii

سال انتشار: 1403
نوع سند: مقاله ژورنالی
زبان: انگلیسی
مشاهده: 98

فایل این مقاله در 12 صفحه با فرمت PDF قابل دریافت می باشد

استخراج به نرم افزارهای پژوهشی:

لینک ثابت به این مقاله:

شناسه ملی سند علمی:

JR_CHM-8-10_002

تاریخ نمایه سازی: 13 آبان 1403

چکیده مقاله:

Multidrug-resistant (MDR) Acinetobacter baumannii poses a critical threat in healthcare settings due to its capacity to evade commonly used antibiotics, particularly through the production of various beta-lactamases. Sulbactam, a beta-lactamase inhibitor with intrinsic bactericidal activity, often requires combination with beta-lactamase inhibitors to restore efficacy. This study investigates the synergistic potential of combining Sulbactam with novel inhibitors—Durlobactam, Avibactam, and ETX۲۵۱۴—against Class A, Class C, and Class D beta-lactamases. Molecular docking, molecular dynamics (MD) simulations, and MM/PBSA binding energy calculations were performed to evaluate the binding affinities of the inhibitors to their respective beta-lactamases. The Chou-Talalay method was applied to assess synergy by calculating Combination Index (CI) values, with CI < ۱ indicating synergy. Durlobactam + Sulbactam demonstrated superior synergy compared to other combinations, with a CI of ۰.۶۲ against Class D, while ETX۲۵۱۴ + Sulbactam exhibited broad-spectrum synergy across all beta-lactamase classes (CI < ۰.۸۰). Avibactam + Sulbactam showed limited synergy against Class D enzymes (CI = ۱.۰۹) but remained effective against Class A and Class C beta-lactamases. The molecular dynamics and MM/PBSA calculations supported these findings, with ETX۲۵۱۴ and Durlobactam showing superior binding stability in the active sites. This study demonstrates the potential of Durlobactam and ETX۲۵۱۴ as highly effective beta-lactamase inhibitors when combined with Sulbactam, particularly against Class D beta-lactamases in MDR Acinetobacter baumannii. These findings highlight the importance of selecting appropriate inhibitors to restore antibiotic efficacy and suggest Sulbactam + ETX۲۵۱۴ as a promising therapeutic option for MDR infections.

نویسندگان

Emine Erdag

Department of Pharmaceutical Chemistry, Faculty of Pharmacy, Near East University, Nicosia, Cyprus

مراجع و منابع این مقاله:

لیست زیر مراجع و منابع استفاده شده در این مقاله را نمایش می دهد. این مراجع به صورت کاملا ماشینی و بر اساس هوش مصنوعی استخراج شده اند و لذا ممکن است دارای اشکالاتی باشند که به مرور زمان دقت استخراج این محتوا افزایش می یابد. مراجعی که مقالات مربوط به آنها در سیویلیکا نمایه شده و پیدا شده اند، به خود مقاله لینک شده اند :
  • . Cavallo I., Oliva A., Pages R., Sivori F., Truglio ...
  • . Ayoub Moubareck C.,Hammoudi Halat D., Insights into acinetobacter baumannii: ...
  • . Elbehiry A., Marzouk E., Moussa I., Mushayt Y., Algarni ...
  • . Kyriakidis I., Vasileiou E., Pana Z.D.,Tragiannidis A., Acinetobacter baumannii ...
  • . Zhang S., Liao X., Ding T.,Ahn J., Role of ...
  • . Gaurav A., Bakht P., Saini M., Pandey S., Pathania ...
  • . a) Sajjadifar S., Abakhsh F.,Arzehgar Z., Design and characterization ...
  • b) Giurazza R., Mazza M.C., Andini R., Sansone P., Pace ...
  • . a) Heshmati Jannat Magham A., Naseri Baygi S.M., Inclusion ...
  • . a) Gholamrezazadeh C., Hakimi M., Dadmehr M., A new ...
  • b) Papp-Wallace K.M., The latest advances in β-lactam/β-lactamase inhibitor combinations ...
  • . Pasteran F., Cedano J., Baez M., Albornoz E., Rapoport ...
  • . Durand-Réville T.F., Guler S., Comita-Prevoir J., Chen B., Bifulco ...
  • . Chou T.C., Drug combination studies and their synergy quantification ...
  • . Zhang N., Fu J.N., Chou T.C., Synergistic combination of ...
  • . Genheden S., Ryde U., The mm/pbsa and mm/gbsa methods ...
  • . a) Khamooshi F., Doraji-Bonjar S., Akinnawo A.S., Ghaznavi H., ...
  • b) Thangavel N.,Albratty M., Benchmarked molecular docking integrated molecular dynamics ...
  • . Haskologlu I.C., Erdag E., Sehirli A.O., Uludag O.,Abacioglu N., ...
  • . Erdag E., Haskologlu I.C., Mercan M., Abacioglu N., Sehirli ...
  • . Erdag E., A molecular docking study: Benzoxazolone derivatives against ...
  • . Erdag E., Investigation of some phenolic compounds as inos ...
  • . Haskologlu I.C., Erdag E., Sehirli A.O., Uludag O.,Abacioglu N., ...
  • . Golo V.,Shaĭtan K., Dynamic attractor for the berendsen thermostat ...
  • . Mhaibes R.M., Arzehgar Z., Mirzaei Heydari M., Fatolahi, L. ...
  • . Bernetti M.,Bussi G., Pressure control using stochastic cell rescaling, ...
  • . Hosseini A.N.,van der Spoel D., Martini on the rocks: ...
  • . Ouabane M., Zaki K., Tabti K., Alaqarbeh M., Sbai ...
  • . Shahoodh, M. A., Ibrahim, F., Guermazi, S. Investigations on ...
  • . a) Tadayon N.,Ramazani A., Molecular docking and dynamics analysis ...
  • . Hassan H.M., Evaluation of Several Austenitic Types of Stainless ...
  • . Hasan S.M., Koubaa W.C., Ghazai A.J. Improvement of TiO₂/Au/FTO ...
  • . a) Resen N.D., Gomaa E.A., Salem S.E., El-Defrawy A.M.,Abd ...
  • b) Yuan Z., Chen X., Fan S., Chang L., Chu ...
  • . Rodríguez-Martínez A., Nelen J., Carmena-Bargueño M., Martínez-Cortés C., Luque ...
  • . El Rhabori S., Alaqarbeh M., El Aissouq A., Bouachrine ...
  • . Gonçalves P.F.,Stassen H., Free energy of solvation from molecular ...
  • . a) Ghalandarzehi Y.,Kord T.H., Experimental and theoretical study on ...
  • b) Duarte, D., Vale, N. Res. Pharmacol. Drug Discov., ۲۰۲۲, ...
  • . Spinozzi G., Tini V., Ferrari A., Gionfriddo I., Ranieri ...
  • . Elbehiry A., Marzouk E., Moussa I., Mushayt Y., Algarni ...
  • . a) Tadayon N.,Ramazani A., In silico analysis of sars-cov-۲ ...
  • b) Nocera F.P., Attili A.-R.,De Martino L., Acinetobacter baumannii: Its ...
  • . Ahuatzin-Flores O.E., Torres E.,Chávez-Bravo E., Acinetobacter baumannii, a multidrug-resistant ...
  • . a) Rasen N., Gomaa E.A., Salem S.E., Abd El-Hady ...
  • b) Aurilio C., Sansone P., Barbarisi M., Pota V., Giaccari ...
  • . a) Fadhil G., An efficient cloud point extraction for ...
  • b) Antunes N.T., Lamoureaux T.L., Toth M., Stewart N.K., Frase ...
  • . Penwell W.F., Shapiro A.B., Giacobbe R.A., Gu R.-F., Gao ...
  • . a) Hosseini F., Naddaf E., Fadaee K.J.,Ebrahimi M., Simultaneous ...
  • b) Marino A., Augello E., Stracquadanio S., Bellanca C.M., Cosentino ...
  • . Shapiro A.B., Moussa S.H., McLeod S.M., Durand-Réville T.,Miller A.A., ...
  • . Watkins R.R.,Bonomo R.A., Sulbactam-durlobactam: A step forward in treating ...
  • . Al-Azzawi, M. A., R. Saleh, W. (۲۰۲۳). Fabrication of ...
  • . Papp-Wallace K.M., McLeod S.M.,Miller A.A., Durlobactam, a broad-spectrum serine ...
  • . Segatore B., Piccirilli A., Cherubini S., Principe L., Alloggia ...
  • . Zasowski E.J., Rybak J.M.,Rybak M.J., The β‐lactams strike back: ...
  • . Lahiri S.D., Mangani S., Jahić H., Benvenuti M., Durand-Reville ...
  • . Principe L., Lupia T., Andriani L., Campanile F., Carcione ...
  • . Poulakou G., Lagou S., Karageorgopoulos D.E.,Dimopoulos G., New treatments ...
  • . Barnes M.D., Bethel C.R., Rutter J.D., Akker F.V.D., Papp-Wallace ...
  • . Durand-Réville T.F., Guler S., Comita-Prevoir J., Chen B., Bifulco ...
  • . Laupland K.B.,Valiquette L., The changing culture of the microbiology ...
  • . McLeod S.M., O'Donnell J.P., Narayanan N., Mills J.P.,Kaye K.S., ...
  • . Van Duin D.,Paterson D.L., Multidrug-resistant bacteria in the community: ...
  • . Salam M.A., Al-Amin M.Y., Salam M.T., Pawar J.S., Akhter ...
  • . Muteeb G., Rehman M.T., Shahwan M.,Aatif M., Origin of ...
  • . Rafailidis P., Panagopoulos P., Koutserimpas C.,Samonis G., Current therapeutic ...
  • . Abdi S.N., Ghotaslou R., Ganbarov K., Mobed A., Tanomand ...
  • نمایش کامل مراجع